TBX2 and breast carcinoma: Legumain can activate zymogene progelatinase A, which mediates extracellular matrix degradation29, this interaction may affect tumor invasion and metastasis4 .TBX2 is an oncogenic transcription factor that can drive breast cancer proliferation by maintaining LGMN activity30.